Company Profiles

driven by the PitchBook Platform

AvantiCell Science

AvantiCell Science
2006 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Grant LATEST DEAL TYPE
$2.88M LATEST DEAL AMOUNT
3 INVESTORS
Description

Provider of cell culture technology designed to be used in drug discovery, biomedical research and natural product testing. The company's cell culture technology provides its expertise in a range of services ranging from off-the-shelf cell-based assays to specialist cell culture systems customized to meet customers' requirements and also supplies a growing range of cell products, extending from primary cell isolates to fully validated assay systems, enabling customers to evaluate bio-activity or bio-safety in a wide-range of test materials, from pharmaceuticals, traditional medicines and natural products to medical devices and nano-structured materials.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Gibbsyard Building
  • Auchincruive
  • Ayr KA6 5HW
  • Scotland

+44 01292 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AvantiCell Science’s full profile, request a free trial.

AvantiCell Science Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Grant 27-Oct-2015 $2.88M 00000 Completed Generating Revenue
10. Grant 08-Jul-2014 00000 00000 Completed Generating Revenue
9. Grant 01-Nov-2013 000.00 00000 Completed Generating Revenue
8. Later Stage VC 22-Apr-2013 00000 00000 00.000 Completed Generating Revenue
7. Grant 01-Nov-2012 00000 00000 Completed Generating Revenue
6. Grant 01-Jul-2011 00.000 00000 Completed Startup
5. Early Stage VC 01-Jan-2010 00000 00000 00.000 Completed Startup
4. Grant 01-Oct-2009 00000 Completed Startup
3. Early Stage VC 01-Feb-2009 Completed Startup
2. Early Stage VC 31-Dec-2007 Completed Startup
1. Early Stage VC 01-Dec-2006 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AvantiCell Science Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 00,000 00.00 00.00 00 00.00 0.000
To view this company’s complete Cap Table, request access »

AvantiCell Science Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Horizon 2020 Government 000 0000 000000 0
Barwell Venture Capital Minority 000 0000 000000 0
Scottish Enterprise Venture Capital Minority 000 0000 000000 0

AvantiCell Science Executive Team (2)

Name Title Board
Seat
Contact
Info
Joanna Oliver Co-Founder, Board Member & Chief Executive Officer
Colin Wilde Co-Founder, Board Member & Chief Scientific Officer

AvantiCell Science Board Members (4)

Name Representing Role Since Contact
Info
Colin Wilde AvantiCell Science Co-Founder, Board Member & Chief Scientific Officer 000 0000
Douglas Thomson AvantiCell Science Chairman 000 0000
Joanna Oliver AvantiCell Science Co-Founder, Board Member & Chief Executive Officer 000 0000
Peter Bishop AvantiCell Science Board Member 000 0000